Fulcrum Therapeutics, Inc. - Common Stock (NQ:FULC)

3.690 +0.010 (+0.27%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fulcrum Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

NASDAQ:FULC Long Term Investor Alert: Investigation of Potential Wrongdoing at Fulcrum Therapeutics, Inc. ↗

September 14, 2023

San Diego, CA -- (SBWIRE) -- 09/14/2023 -- Certain directors of Fulcrum Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Wave of FDA Fast Track Designations Highlight Biotech Momentum Carrying into 2023

September 13, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – September 13, 2023 – USA News Group – Sufferers of many different ailments saw reason to grow their hope in 2022 when the US Food...

Via FinancialNewsMedia

Fulcrum Announces Completion of Enrollment in the Phase 3 REACH Clinical Trial of Losmapimod in Facioscapulohumeral Muscular Dystrophy (FSHD)

September 07, 2023

Enrolled 260 patients; topline data expected in the fourth quarter of 2024

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Why Splunk Are Trading Higher By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

August 24, 2023

Gainers Electriq Power Holdings, Inc. (NYSE: ELIQ) shares jumped 130.3% to $3.3847.

Via Benzinga

Dollar Tree, Burlington Stores, Opera And Other Big Stocks Moving Lower On Thursday ↗

August 24, 2023

U.S. stocks traded lower, with the Dow Jones falling over 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Fulcrum Therapeutics To Rally Around 120%? FDA Update Removes Overhang On Pivotal Program ↗

August 23, 2023

Tuesday, the FDA lifted the clinical hold on Fulcrum Therapeutics Inc's (NASDAQ: FULC) Investigational New Drug (IND) application for FTX-6058 for the potential treatment of

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2023 ↗

August 23, 2023

Via Benzinga

Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views ↗

August 22, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.39% to 34,330.87 while the NASDAQ rose 0.24% to 13,530.50. The...

Via Benzinga

Topics Earnings Stocks

Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 22, 2023

Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) shares jumped 42.8% to $5.60 after the FDA lifted clinical hold on the company’s FTX-6058 for sickle cell disease.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

August 22, 2023

Via Benzinga

Dow Falls Over 100 Points; US Existing Home Sales Decline In July ↗

August 22, 2023

U.S. stocks traded mixed midway through trading, with the Dow Jones falling over 100 points on Tuesday. The Dow traded down 0.32% to 34,354.22 while the NASDAQ rose 0.52% to 13,567.52. The S&P 500,...

Via Benzinga

Topics Stocks

Fulcrum Therapeutics Inc. (NASDAQ: FULC) Near Top of Volume Charts in Tuesday Trading

August 22, 2023

Via Investor Brand Network

Why Is Fulcrum Therapeutics Stock Surging Today? ↗

August 22, 2023

Fulcrum Therapeutics Inc (NASDAQ: FULC) shares are trading higher after the FDA lifted the clinical hold on the Investigational New Drug (IND) application for FTX-6058 for the potential treatment of

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 22, 2023 ↗

August 22, 2023

Via Benzinga

Fulcrum Therapeutics, AMTD Digital, Hasbro And Other Big Stocks Moving Higher On Tuesday ↗

August 22, 2023

U.S. stocks traded mixed, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

BLNK Stock Alert: Blink Charging Signs Deal to Bring EV Charging to McDonald’s ↗

August 22, 2023

Blink Charging (BLNK) stock is on the move Tuesday after the EV charging company signed a deal that brings its services to McDonald's (MCD).

Via InvestorPlace

US Stocks Mixed; Lowe's Posts Upbeat Earnings ↗

August 22, 2023

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.07% to 34,439.33 while the NASDAQ rose...

Via Benzinga

Topics Stocks

APP Stock Price Predictions: Is AppLovin Really Worth $50? ↗

August 22, 2023

Applovin (APP) stock is in the news Tuesday after the stock got a new price target from Jefferies analyst Andrew Uerkwitz.

Via InvestorPlace

Why Is Fulcrum Therapeutics (FULC) Stock Up 43% Today? ↗

August 22, 2023

Fulcrum Therapeutics (FULC) stock is on the rise Tuesday after the FDA removed a clinical hold on its sickle-cell disease candidate.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 22, 2023

Via Benzinga

FDA Lifts Clinical Hold on Fulcrum Therapeutics’ FTX-6058 for Sickle Cell Disease

August 22, 2023

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 11, 2023

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Second Quarter 2023

August 03, 2023

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics Appoints Chief Financial Officer

August 03, 2023

— Alan A. Musso appointed as CFO effective August 7, 2023 —

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics to Host Second Quarter 2023 Financial Results Conference Call and Webcast on Thursday, August 3, 2023, at 8:00 a.m. ET

July 27, 2023

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics Signs Exclusive Global License Agreement in Rare Hematology

July 10, 2023

CAMP4 Therapeutics grants exclusive rights to advance novel therapies for Diamond-Blackfan Anemia

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

July 07, 2023

From Fulcrum Therapeutics, Inc.

Via GlobeNewswire

The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fulcrum Therapeutics, Inc. (FULC)

June 26, 2023

From The Law Offices of Frank R. Cruz

Via Business Wire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edgio, Fulcrum, adidas, and Spirit AeroSystems and Encourages Investors to Contact the Firm

June 25, 2023

From Bragar Eagel & Squire

Via GlobeNewswire

FULC DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fulcrum Therapeutics, Inc. Investors to Secure Counsel Before Important June 27 Deadline in Securities Class Action - FULC

June 23, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

< Previous 1 2 3 4 5 6 7 8 9

...

14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.